Tags: FDA | approval | bleeding disorder | hemophilia A | Obizur

Drug to Treat Hemophilia

Friday, 24 Oct 2014 12:48 PM


Drugmaker Baxter International Inc said the U.S. Food and Drug Administration had approved its drug for treating bleeding episodes in adults with a rare bleeding disorder.
The drug, Obizur, has been approved for use in patients with acquired hemophilia A, which usually affects older adults, Baxter said in a statement.
The drug will be launched in the United States in the coming months and is being reviewed by European and Canadian regulators, the company said.

© 2017 Thomson/Reuters. All rights reserved.

 
1Like our page
2Share
Health-Wire
Drugmaker Baxter International Inc said the U.S. Food and Drug Administration had approved its drug for treating bleeding episodes in adults with a rare bleeding disorder.The drug, Obizur, has been approved for use in patients with acquired hemophilia A, which usually...
FDA, approval, bleeding disorder, hemophilia A, Obizur
75
2014-48-24
Friday, 24 Oct 2014 12:48 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved